Diagnostic Hybrids to Manufacture, Distribute Cell Products for CRO KaLy-Cell
 
Diagnostic Hybrids, a manufacturer of cellular and molecular diagnostic kits, announced this week that it has executed a technology transfer and supply agreement with contract research organization KaLy-Cell.
 
The agreement calls for Diagnostic Hybrids to manufacture and distribute hepatocytes and subcellular fractions from humans and several large and small animal species to KaLy-Cell.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.